Notice of Change in Key Dates for PAR-18-630 "Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)"
PAR-18-630
Current dates:
Revised dates (in italics):
All other aspects of the FOA remain unchanged.
Notice Number: NOT-AI-18-027
Key Dates
Release Date: April 11, 2018
PAR-18-630
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
Purpose
The purpose of this Notice is to inform potential applicants of changes to Key Dates for PAR-18-630 " Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)". The Application Due Date(s) has been revised.
Part 1. Key Dates
Current dates:
| Posted Date | February 5, 2018 |
| Open Date (Earliest Submission Date) | March 10, 2018 |
| Letter of Intent Due Date(s) | 30 days prior to the application due date |
| Application Due Date(s) | April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) | April 10, 2018; December 7, 2018; March 7, 2019; December 6, 2019, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | July 2018; March 2019; June 2019; March 2020 |
| Advisory Council Review | October 2018; May 2019; August/September 2019; May 2020 |
| Earliest Start Date | December 2018; July 2019; September 2019; July 2020 |
| Expiration Date | December 7, 2019 |
| Due Dates for E.O. 12372 | Not Applicable |
Revised dates (in italics):
| Posted Date | February 5, 2018 |
| Open Date (Earliest Submission Date) | March 10, 2018 |
| Letter of Intent Due Date(s) | 30 days prior to the application due date |
| Application Due Date(s) | April 10, 2018; December 7, 2018; March 7, 2019; December 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| AIDS Application Due Date(s) | April 10, 2018; December 7, 2018; March 7, 2019; December 6, 2019, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | July 2018; March 2019; June 2019; March 2020 |
| Advisory Council Review | October 2018; May 2019; August/September 2019; May 2020 |
| Earliest Start Date | December 2018; July 2019; September 2019; July 2020 |
| Expiration Date | December 7, 2019 |
| Due Dates for E.O. 12372 | Not Applicable |
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Kenneth Santora, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2933
Email: [email protected]
Department of Health
and Human Services (HHS)
and Human Services (HHS)
